Department of Pharmacology & Toxicology, The University of Texas Medical Branch, Galveston, TX 77555, USA.
Int J Mol Sci. 2024 Jul 24;25(15):8069. doi: 10.3390/ijms25158069.
The signaling complex around voltage-gated sodium (Nav) channels includes accessory proteins and kinases crucial for regulating neuronal firing. Previous studies showed that one such kinase, WEE1-critical to the cell cycle-selectively modulates Nav1.2 channel activity through the accessory protein fibroblast growth factor 14 (FGF14). Here, we tested whether WEE1 exhibits crosstalk with the AKT/GSK3 kinase pathway for coordinated regulation of FGF14/Nav1.2 channel complex assembly and function. Using the in-cell split luciferase complementation assay (LCA), we found that the WEE1 inhibitor II and GSK3 inhibitor XIII reduce the FGF14/Nav1.2 complex formation, while the AKT inhibitor triciribine increases it. However, combining WEE1 inhibitor II with either one of the other two inhibitors abolished its effect on the FGF14/Nav1.2 complex formation. Whole-cell voltage-clamp recordings of sodium currents (I) in HEK293 cells co-expressing Nav1.2 channels and FGF14-GFP showed that WEE1 inhibitor II significantly suppresses peak I density, both alone and in the presence of triciribine or GSK3 inhibitor XIII, despite the latter inhibitor's opposite effects on I. Additionally, WEE1 inhibitor II slowed the tau of fast inactivation and caused depolarizing shifts in the voltage dependence of activation and inactivation. These phenotypes either prevailed or were additive when combined with triciribine but were outcompeted when both WEE1 inhibitor II and GSK3 inhibitor XIII were present. Concerted regulation by WEE1 inhibitor II, triciribine, and GSK3 inhibitor XIII was also observed in long-term inactivation and use dependency of Nav1.2 currents. Overall, these findings suggest a complex role for WEE1 kinase-in concert with the AKT/GSK3 pathway-in regulating the Nav1.2 channelosome.
电压门控钠 (Nav) 通道周围的信号复合物包括辅助蛋白和激酶,这些对于调节神经元放电至关重要。先前的研究表明,一种这样的激酶——WEE1——通过辅助蛋白成纤维细胞生长因子 14(FGF14)对细胞周期具有选择性,调节 Nav1.2 通道活性。在这里,我们测试了 WEE1 是否与 AKT/GSK3 激酶途径相互作用,以协调调节 FGF14/Nav1.2 通道复合物的组装和功能。使用细胞内分裂荧光素酶互补测定(LCA),我们发现 WEE1 抑制剂 II 和 GSK3 抑制剂 XIII 减少了 FGF14/Nav1.2 复合物的形成,而 AKT 抑制剂曲昔派汀则增加了复合物的形成。然而,将 WEE1 抑制剂 II 与其他两种抑制剂中的任一种结合使用,均可消除其对 FGF14/Nav1.2 复合物形成的影响。在共表达 Nav1.2 通道和 FGF14-GFP 的 HEK293 细胞中的全细胞电压钳记录钠电流(I)表明,WEE1 抑制剂 II 可显著抑制 I 的峰值密度,无论是单独使用还是与曲昔派汀或 GSK3 抑制剂 XIII 一起使用,尽管后者抑制剂对 I 有相反的作用。此外,WEE1 抑制剂 II 减慢了快速失活的 tau,并引起激活和失活的电压依赖性的去极化偏移。当与曲昔派汀结合使用时,这些表型占主导地位或具有加性,但当同时存在 WEE1 抑制剂 II 和 GSK3 抑制剂 XIII 时,则被竞争掉。在 Nav1.2 电流的长期失活和使用依赖性中,也观察到 WEE1 抑制剂 II、曲昔派汀和 GSK3 抑制剂 XIII 的协同调节作用。总的来说,这些发现表明 WEE1 激酶与 AKT/GSK3 途径协同调节 Nav1.2 通道体的复杂作用。